As of August 2024 VistaGen Therapeutics has 6.96M shares outstanding, a increase of 5.45% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 6.96M | 5.45% |
2022 | 6.60M | 129.87% |
2021 | 2.87M | 96.34% |
2020 | 1.46M | - |